We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Global POC Ultrasound Devices Market to Surpass USD 4.5 Billion by 2030 Due to Booming Geriatric Population

By MedImaging International staff writers
Posted on 21 Dec 2021
Print article
Illustration
Illustration

The global point-of-care ultrasound (PoCUS) devices market is projected to grow at a CAGR of 7.9% from more than USD 2 billion in 2020 to over USD 4.5 billion by 2030, driven by the booming geriatric population across the world.

These are the latest findings of Research and Markets (Dublin Ireland), a leading source for international market research and data.

The COVID-19 impact on the PoCUS devices market has been negative due to the closure of manufacturing facilities. Moreover, almost all the healthcare resources were diverted to the fight against the pandemic, which is why most diagnostic imaging facilities were shut down, except for COVID patients.

Based on type, the diagnostic segment holds the largest share of the PoCUS devices market as such devices are being increasingly utilized for evaluating left ventricular systolic function and diagnosing severe mitral regurgitation, pericardial effusion, pleural effusion, pulmonary edema, and pneumothorax. Over the coming years, the portability segment of the PoCUS devices market will be dominated by the trolley/cart-based segment as these devices find widespread usage in hospitals where they can be easily taken from one place to another, such as between radiology departments and emergency rooms (ER).

Based on application, the emergency medicine segment is expected to record the highest CAGR in the PoCUS devices market during the forecast period. As shifting the patient from the ER to the ultrasound ward can result in loss of valuable time, portable ultrasound devices are being used at the bedside to obtain immediate clinical information, increase efficiency, improve patient safety, and decrease the risk of complications.

Geographically, Europe generates the highest revenue in the global PoCUS devices market due to the increasing incidence of chronic diseases, healthcare expenditure, and geriatric population in the region, as well as rapid technological advancements in radiology. According to the UN, the region's geriatric population will increase from 140.4 million in 2019 to 199.9 million by 2050, thus driving the volume of ultrasound procedures. Asia-Pacific (APAC) will be the fastest-growing PoCUS devices market in the years to come owing to the rising demand for point-of-care treatment and diagnosis, increasing healthcare expenditure, and surging cases of lifestyle-associated and chronic diseases. Moreover, Asia’s aging population is set to reach 0.95 billion by 2050 from nearly 0.4 billion in 2019, according to the UN.

Related Links:
Research and Markets 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ceiling-Mounted Digital Radiography System
Radiography 5000 C
Portable Radiology System
DRAGON ELITE & CLASSIC
Ultrasound Software
UltraExtend NX

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.